Judge to Unseal Documents on the Eli Lilly Drug Zyprexa

A federal judge in Brooklyn decided on Friday to unseal confidential materials about Eli Lilly’s
top-selling antipsychotic drug Zyprexa, citing “the health of hundreds
of thousands of people” and “fundamental questions” about the way drugs
are approved for new uses.

The decision by Judge Jack B. Weinstein
of Federal District Court came as part of a ruling that gave
class-action status to a case brought by insurance companies, pension
funds and unions that want Lilly to repay them billions of dollars they
spent on the drug. They contend that Lilly hid the side effects of the
drug and marketed it for unapproved uses.

The confidential documents were produced by Lilly in response to a
related lawsuit filed by patients who said that Zyprexa had caused
excessive weight gain and diabetes. The papers were placed under a
protective court order soon after the suit was filed in 2004.

“Lilly’s legitimate interest in confidentiality does not outweigh
the public interest in disclosure at this stage,” Judge Weinstein
wrote.

A spokeswoman for Lilly, Marni Lemons, said the company would not
appeal the decision to make the documents public but that it would
appeal the judge’s certification of a class action.

The issue of confidential information arose in 2006, when some of
the Zyprexa papers were provided to a reporter for The New York Times,
Alex Berenson. He wrote front-page articles based on evidence they
contained that Lilly executives had kept information from doctors about
Zyprexa’s links to obesity and high blood sugar.

Eli Lilly denied having withheld such information and said that the
documents Mr. Berenson had seen were “cherry-picked” to give a
one-sided view.

The publication of sealed information led Judge Weinstein to issue a
sharply worded ruling last year, stating that Mr. Berenson had engaged
in a conspiracy with a doctor and a lawyer and that they had used
others “as their agents in crime.”

The judge said the sealed documents belonged to Lilly and ordered
the doctor, David S. Egilman, and the lawyer, James B. Gottstein, to
return them. Dr. Egilman had been serving as an expert consultant for
the plaintiffs at the time, and Mr. Gottstein was working on Zyprexa
litigation in Alaska.

Since then, insurance companies, unions, medical researchers and
other publications have filed formal requests for copies of the
documents. Many of the papers were entered into open court proceedings
in Alaska, and copies of some have been posted on the Internet.

In his ruling on Friday, Judge Weinstein repeated that the
information had been “obtained illegally” by The Times but also cited
“this country’s general policy of accessibility of court records.”

Dr. Egilman said on Friday that he felt vindicated.

“The public can now decide for itself what these documents stand for,” he said.

Mr. Gottstein said he still disputed Judge Weinstein’s rulings that he had obtained the documents illegally.

“I think I did get them properly,” he said, adding that the new
order unsealed only a small number of the Zyprexa documents that Lilly
has provided to the court. “There are a lot of other documents that are
hidden.”